Integer Holdings Corp (ITGR) is a leading medical device company that specializes in the development and manufacturing of advanced medical technologies. The company's strong financial performance is reflected in its income statement, which provides a comprehensive view of its revenues and expenses. With a total revenue of $1.45 billion, the company has demonstrated its ability to generate significant sales. Its gross profit stands at $600 million, indicating a healthy margin. Net income from stockholders is reported at $130 million, highlighting the company's profitability. EBIT and EBITDA, which measure operational earnings, are reported at $180 million and $230 million respectively. These figures reflect the company's strong financial position and its ability to generate profits from its core operations.
Turning our attention to the balance sheet, Integer Holdings Corp (ITGR) has a solid financial foundation. The company reports total assets of $2.5 billion, demonstrating its significant asset base. Stockholders' equity, which showcases the company's net worth, stands at $1.4 billion. This indicates that the company maintains a healthy ownership interest. When it comes to total debt, the company reports $700 million, suggesting a manageable level of indebtedness. Net debt, which subtracts cash equivalents from total debt, is reported at $600 million. This figure indicates that the company has a relatively low net debt position. Total liabilities are reported at $1.1 billion, highlighting the company's obligations and claims against its assets.
Lastly, we examine the company's cash flow. Integer Holdings Corp (ITGR) has a robust cash flow management system. Operating cash flow, which represents the cash generated from the company's core operations, is reported at $200 million. This figure indicates the company's ability to generate cash from its day-to-day business activities. On the other hand, financing cash flow, which captures the cash flows related to financing activities such as debt issuance or repayment, is reported at -$50 million. This suggests that the company has utilized more cash for financing purposes. Investing cash flow, which represents the cash flows related to investments in fixed assets or marketable securities, is reported at -$30 million. Lastly, free cash flow, which measures the cash left after deducting capital expenditures, stands at $170 million. This figure reflects the company's ability to generate excess cash for other purposes.